In Vitro-In Vivo Extrapolation Method to Predict Human Renal Clearance of Drugs

被引:29
|
作者
Kunze, Annett [1 ,2 ]
Huwyler, Joerg [2 ]
Poller, Birk [1 ]
Gutmann, Heike [1 ]
Camenisch, Gian [1 ]
机构
[1] Novartis Inst BioMed Res, Drug Drug Interact Sect, Div Drug Metab & Pharmacokinet, CH-4056 Basel, Switzerland
[2] Univ Basel, Div Pharmaceut Technol, Dept Pharmaceut Sci, CH-4056 Basel, Switzerland
关键词
in vitro-in vivo correlations (IVIVC); renal clearance; renal reabsorption; permeability; drug transport; in vitro models; membrane transport; pharmacokinetics; LLC-PK1 cell line; clearance prediction; TRANSCELLULAR TRANSPORT; MEMBRANE TRANSPORTERS; LLC-PK1; KIDNEY; PARAMETERS; METABOLISM; MECHANISMS; MONOLAYERS; EXPRESSION; MODEL;
D O I
10.1002/jps.23851
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Renal clearance is a key determinant of the elimination of drugs. To date, only few in vitro-in vivo extrapolation (IVIVE) approaches have been described to predict the renal organ clearance as the net result of glomerular filtration, tubular secretion, and tubular reabsorption. In this study, we measured in LLC-PK1 cells the transport of 20 compounds that cover all four classes of the Biopharmaceutical Drug Disposition System. These data were incorporated into a novel kidney model to predict all renal clearance processes in human. We showed that filtration and secretion were main contributors to the renal organ clearance for all compounds, whereas reabsorption was predominant for compounds assigned to classes 1 and 2. Our results suggest that anionic drugs were not significantly secreted in LLC-PK1 cells, resulting in under-predicted clearances. When all study compounds were included a high overall correlation between the reported and predicted renal organ clearances was obtained (R-2 = 0.83). The prediction accuracy in terms of percentage within twofold and threefold error was 70% and 95%, respectively. In conclusion, our novel IVIVE method allowed to predict the human renal organ clearance and the contribution of each underlying process. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:994 / 1001
页数:8
相关论文
共 50 条
  • [11] In vitro-in vivo Extrapolation of Transporter-mediated Clearance in the Liver and Kidney
    Kusuhara, Hiroyuki
    Sugiyama, Yuichi
    DRUG METABOLISM AND PHARMACOKINETICS, 2009, 24 (01) : 37 - 52
  • [12] In Vitro-In Vivo Correlation for Intrinsic Clearance for Drugs Metabolized by Human Aldehyde Oxidase
    Zientek, Michael
    Jiang, Ying
    Youdim, Kuresh
    Obach, R. Scott
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (08) : 1322 - 1327
  • [13] In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes
    Tess, David C.
    Chang, George
    Keefer, Christopher
    Carlo, Anthony
    Jones, Rhys
    Di, Li
    AAPS JOURNAL, 2023, 25 (03):
  • [14] The Comparison of Machine Learning and Mechanistic In Vitro-In Vivo Extrapolation Models for the Prediction of Human Intrinsic Clearance
    Keefer, Christopher E.
    Chang, George
    Di, Li
    Woody, Nathaniel A.
    Tess, David A.
    Osgood, Sarah M.
    Kapinos, Brendon
    Racich, Jill
    Carlo, Anthony A.
    Balesano, Amanda
    Ferguson, Nicholas
    Orozco, Christine
    Zueva, Larisa
    Luo, Lina
    MOLECULAR PHARMACEUTICS, 2023, 20 (11) : 5616 - 5630
  • [15] Scaling factors for the in vitro-in vivo extrapolation (IV-IVE) of renal drug and xenobiotic glucuronidation clearance
    Knights, Kathleen M.
    Spencer, Shane M.
    Fallon, John K.
    Chau, Nuy
    Smith, Philip C.
    Miners, John O.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (06) : 1153 - 1164
  • [16] In vitro-in vivo extrapolation of clearance: Modeling hepatic metabolic clearance of highly bound drugs and comparative assessment with existing calculation methods
    Poulin, Patrick
    Kenny, Jane R.
    Hop, Cornelis E. C. A.
    Haddad, Sami
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (02) : 838 - 851
  • [17] Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches
    Izumi, Saki
    Nozaki, Yoshitane
    Komori, Takafumi
    Takenaka, Osamu
    Maeda, Kazuya
    Kusuhara, Hiroyuki
    Sugiyama, Yuichi
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (09) : 2678 - 2687
  • [18] In vitro kinetics in quantitative in vitro-in vivo extrapolation
    Kramer, Nynke I.
    TOXICOLOGY LETTERS, 2016, 258 : S4 - S4
  • [19] Clearance Prediction of Targeted Covalent Inhibitors by In Vitro-In Vivo Extrapolation of Hepatic and Extrahepatic Clearance Mechanisms
    Leung, Louis
    Yang, Xin
    Strelevitz, Timothy J.
    Montgomery, Justin
    Brown, Matthew F.
    Zientek, Michael A.
    Banfield, Christopher
    Gilbert, Adam M.
    Thorarensen, Atli
    Dowty, Martin E.
    DRUG METABOLISM AND DISPOSITION, 2017, 45 (01) : 1 - 7
  • [20] Evaluating In Vitro-In Vivo Extrapolation of Toxicokinetics
    Wambaugh, John F.
    Hughes, Michael F.
    Ring, Caroline L.
    MacMillan, Denise K.
    Ford, Jermaine
    Fennell, Timothy R.
    Black, Sherry R.
    Snyder, Rodney W.
    Sipes, Nisha S.
    Wetmore, Barbara A.
    Westerhout, Joost
    Setzer, R. Woodrow
    Pearce, Robert G.
    Simmons, Jane Ellen
    Thomas, Russell S.
    TOXICOLOGICAL SCIENCES, 2018, 163 (01) : 152 - 169